IMU 2.56% 3.8¢ imugene limited

I don't think they are terrible(there are respondents and...

  1. 18 Posts.
    I don't think they are terrible(there are respondents and disease is stabilized well). There is good evidence in patients who showed anti tumor activity and no dose limitations/safety issues. However trail being limited to one center and there is still room for better selection of patients(the group is very heterogeneous) and they were heavily pre-treated and proper randomization is lacking. I believe with more centers and better clinical trail design and measurement, it will probably have more promising results.

    The reason I am buying huge shares of IMU is the the diversity of pipeline and amazing researchers. More over I like the B cell concept to be innovative.
 
watchlist Created with Sketch. Add IMU (ASX) to my watchlist
(20min delay)
Last
3.8¢
Change
-0.001(2.56%)
Mkt cap ! $386.7M
Open High Low Value Volume
3.8¢ 3.9¢ 3.8¢ $423.0K 11.10M

Buyers (Bids)

No. Vol. Price($)
1 141633 3.8¢
 

Sellers (Offers)

Price($) Vol. No.
3.9¢ 1926108 10
View Market Depth
Last trade - 16.10pm 25/11/2024 (20 minute delay) ?
IMU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.